학술논문
A randomised phase 2 study of intermittent versus continuous dosing of dabrafenib plus trametinib in patients with BRAFV600 mutant advanced melanoma (INTERIM)
Document Type
Article
Author
Dayimu, Alimu; Gupta, Avinash; Matin, Rubeta N.; Nobes, Jenny; Board, Ruth; Payne, Miranda; Rao, Ankit; Fusi, Alberto; Danson, Sarah; Eccles, Bryony; Carser, Judith; Brown, Ciara O’Hanlon; Steven, Neil; Bhattacharyya, Madhumita; Brown, Ewan; Gonzalez, Michael; Highley, Martin; Pickering, Lisa; Kumar, Satish; Waterston, Ashita; Burghel, George; Demain, Leigh; Baker, Eleanor; Wulff, Jerome; Qian, Wendi; Twelves, Sophie; Middleton, Mark; Corrie, Pippa
Source
In European Journal of Cancer January 2024 196
Subject
Language
ISSN
0959-8049